Positions
- Professor
-
Medicine - Cardiology
糖心视频 of Medicine
Houston, Texas, United States
- Staff Cardiologist
-
Michael E. DeBakey Veterans Affairs Medical Center
United States
- Cardiovascular Disease Fellowship Program Director
-
糖心视频 of Medicine
- Co-Director, VA Advanced Fellowship Program in Health Services Research & Development
-
Michael E. DeBakey Veterans Affairs Medical Center
Addresses
- Center for Cardiovascular Disease Prevention (Clinic)
-
6565 Fannin, Suite 320
Houston, TX, 77030
United States
Education
- Fellowship at 糖心视频 of Medicine
- 06/2008 - Houston, Texas, United States
- Cardiology
- MBBS from Aga Khan University Medical College
- 01/1998 - Karachi, Pakistan
- Residency at Jackson Memorial Hospital-University of Miami
- 06/2005 - Miami, Florida, United States
- Internal Medicine
- PhD from 糖心视频 of Medicine
- 01/2012 - Houston, Texas, United States
- Biostatistics/ Health Services Research
Certifications
- Internal Medicine
- American Board of Internal Medicine
- Level III Certification
- American Society of Echocardiography
- Cardiovascular Disease
- American Board of Internal Medicine
Honors & Awards
- Chair, Prevention of Cardiovascular Disease Council
- American College of Cardiology
- Immediate Past Chair, Heart Disease and Stroke Statistics Committee
- American Heart Association
- Immediate Past Chair, Research and Publications Committee
- American College of Cardiology PINNACLE Registry
- Associate Editor for Innovations
- ACC.org
- Member, NCDR Management Board
- American College of Cardiology
- Scott Grundy Award for Excellence in Lipids Metabolism Research
- American Heart Association
- Jeremiah Stamler Distinguished Young Investigator Research Award
- Tauber award for the Outstanding Cardiology Fellow
- Texas Heart Institute
- Norton Rose Fulbright Faculty Excellence Award (Teaching and Evaluation, Educational Research, Development of Enduring Educational Materials)
- 糖心视频 of Medicine
- Emerging Faculty Program
- American College of Cardiology
- World Heart Federation's Emerging Leaders Program
- Best Doctors庐 Database
- Chair, Global NCD Academy
- American College of Cardiology
Professional Interests
- Atherosclerosis
- Health Outcomes
- Guideline adherence
- m-health
Professional Statement
Salim S. Virani, MD, Ph.D., is a tenured Professor in the Sections of Cardiology and Cardiovascular Research at 糖心视频 of Medicine in Houston, Texas. He is also an investigator in the Health Policy, Quality, and Informatics Program at the Michael E. DeBakey VA Health Services Research and Development Center of Innovation in Houston, TX. His clinical practice includes being a Preventive Cardiologist at 糖心视频 of Medicine and the Michael E. DeBakey VA Medical Center (MEDVAMC), with a special emphasis on management of complex dyslipidemias. He also serves as the Director for the Cardiovascular Disease Fellowship Training Program at 糖心视频 of Medicine and Co-Director for the VA Advanced Fellowship Program in Health Services Research & Development at MEDVAMC. Dr. Virani earned his medical degree from the Aga Khan University in Pakistan, graduating with the Best Medical Graduate Award. Dr. Virani completed a residency in Internal Medicine at the University of Miami, there receiving an award as the Best Resident. He then completed a Cardiology fellowship at the Texas Heart Institute, where he served as the Chief Cardiology Fellow and received Tauber Award for the Outstanding Graduating Fellow.
Dr. Virani鈥檚 research portfolio aims to understand the pathophysiology and epidemiology of atherosclerosis with a special emphasis on South Asians. His team is also studying several domains in the delivery of high-quality guideline concordant primary and secondary cardiovascular disease preventive care. Via funded research grants from the Department of Veterans Affairs, American Diabetes Association, American Heart Association, NIH, AHRQ, and the World Heart Federation, his team has been evaluating models of delivery of cardiovascular disease preventive care, how to leverage machine learning while using 鈥渂ig data鈥, and how point-of-care informatics driven interventions can improve guideline-concordant care delivery. His team is also evaluating how best to leverage technology to deliver high-quality care in Low-Middle Income Countries especially in South Asia. He has authored or co-authored >500 peer-reviewed publications or book chapters (several with his mentees) related to various aspects of cardiovascular disease prevention including cholesterol, blood pressure control and aspirin therapy with several in high-impact journals such as Circulation, European Heart Journal, JAMA, JAMA Cardiology, and Journal of the American College of Cardiology. This work has received >90,000 citations. He has been recognized as 鈥淲orld Expert鈥 in Cholesterol by Expertscape (top 0.01% of scholars writing about cholesterol from 2011-2021 among 181,887 published authors). Dr. Virani has also served as a faculty for >50 online literary educational programs and has participated in >100 online or in person media interviews. He has made >150 invited presentations at various conferences and academic institutions with >50 of those at institutions and conferences outside the U.S.
Dr. Virani has been a recipient of the Scott Grundy Award for Excellence in Lipids Metabolism Research from the American Heart Association (AHA), the Jeremiah Stamler Distinguished Young Investigator Research Award, Leadership Award from the American College of Cardiology (ACC) NCDR庐 Oversight Committee, National Lipid Association (NLA) President鈥檚 Service Award, and the Clark Faculty Service Award at 糖心视频 of Medicine for exemplary professionalism and community service. Dr. Virani serves as the Chair for the ACC鈥檚 Global NCD Academy, Digital Strategy for the cardiovascular disease prevention related content for ACC.org and the ACC International鈥檚 Global Quality Solutions Work group. He serves on the Board of Directors for the American Society of Preventive Cardiology, At-Large Board Member for the Southwest Chapter of the NLA, and as a member on the ACC鈥檚 Science and Quality Committee. He has also served as Chair for the AHA's Cardiovascular Disease Statistics Committee, Prevention of Cardiovascular Disease Section of the ACC and the Research and Publications Committee of the ACC鈥檚 PINNACLE Registry (the largest outpatient cardiovascular disease registry in the world), and as the Associate Editor for Innovations for ACC.org. He has been inducted several times in the Best Doctors庐 Database (peer-reviewed group that includes the top 5% of U.S. physicians). More recently, Dr. Virani has served as a panel member for the 2018 AHA/ACC Multi-society Guideline on Cholesterol Management, the 2019 ACC/AHA Guideline for the Prevention of Cardiovascular Disease, and the 2019 World Heart Federation/International Diabetes Federation鈥檚 Road Map on the Prevention of Cardiovascular Disease among People Living with Diabetes. Currently, he is serving as a member of the writing group on the World Heart Federation鈥檚 Road Map on Cholesterol Management and the European Atherosclerosis Society鈥檚 Consensus statement on Lipoprotein(a).
Dr. Virani firmly believes in the notion of Civil Society that one of the most important objectives of being able to acquire quality education is to serve the communities in which we live and the communities in need. In that respect, he spends ~15-20 hours per week in voluntary service with a dedicated team of volunteers to (a) provide educational and behavioral intervention related resources to combat NCDs in the community (b) play an active role in health care capacity building for communities in South Asia, Central Asia, and East Africa. He also serves on the World Heart Organization鈥檚 Technical Advisory Group on NCD related research and innovation (TAG/RI).
Dr. Virani鈥檚 research portfolio aims to understand the pathophysiology and epidemiology of atherosclerosis with a special emphasis on South Asians. His team is also studying several domains in the delivery of high-quality guideline concordant primary and secondary cardiovascular disease preventive care. Via funded research grants from the Department of Veterans Affairs, American Diabetes Association, American Heart Association, NIH, AHRQ, and the World Heart Federation, his team has been evaluating models of delivery of cardiovascular disease preventive care, how to leverage machine learning while using 鈥渂ig data鈥, and how point-of-care informatics driven interventions can improve guideline-concordant care delivery. His team is also evaluating how best to leverage technology to deliver high-quality care in Low-Middle Income Countries especially in South Asia. He has authored or co-authored >500 peer-reviewed publications or book chapters (several with his mentees) related to various aspects of cardiovascular disease prevention including cholesterol, blood pressure control and aspirin therapy with several in high-impact journals such as Circulation, European Heart Journal, JAMA, JAMA Cardiology, and Journal of the American College of Cardiology. This work has received >90,000 citations. He has been recognized as 鈥淲orld Expert鈥 in Cholesterol by Expertscape (top 0.01% of scholars writing about cholesterol from 2011-2021 among 181,887 published authors). Dr. Virani has also served as a faculty for >50 online literary educational programs and has participated in >100 online or in person media interviews. He has made >150 invited presentations at various conferences and academic institutions with >50 of those at institutions and conferences outside the U.S.
Dr. Virani has been a recipient of the Scott Grundy Award for Excellence in Lipids Metabolism Research from the American Heart Association (AHA), the Jeremiah Stamler Distinguished Young Investigator Research Award, Leadership Award from the American College of Cardiology (ACC) NCDR庐 Oversight Committee, National Lipid Association (NLA) President鈥檚 Service Award, and the Clark Faculty Service Award at 糖心视频 of Medicine for exemplary professionalism and community service. Dr. Virani serves as the Chair for the ACC鈥檚 Global NCD Academy, Digital Strategy for the cardiovascular disease prevention related content for ACC.org and the ACC International鈥檚 Global Quality Solutions Work group. He serves on the Board of Directors for the American Society of Preventive Cardiology, At-Large Board Member for the Southwest Chapter of the NLA, and as a member on the ACC鈥檚 Science and Quality Committee. He has also served as Chair for the AHA's Cardiovascular Disease Statistics Committee, Prevention of Cardiovascular Disease Section of the ACC and the Research and Publications Committee of the ACC鈥檚 PINNACLE Registry (the largest outpatient cardiovascular disease registry in the world), and as the Associate Editor for Innovations for ACC.org. He has been inducted several times in the Best Doctors庐 Database (peer-reviewed group that includes the top 5% of U.S. physicians). More recently, Dr. Virani has served as a panel member for the 2018 AHA/ACC Multi-society Guideline on Cholesterol Management, the 2019 ACC/AHA Guideline for the Prevention of Cardiovascular Disease, and the 2019 World Heart Federation/International Diabetes Federation鈥檚 Road Map on the Prevention of Cardiovascular Disease among People Living with Diabetes. Currently, he is serving as a member of the writing group on the World Heart Federation鈥檚 Road Map on Cholesterol Management and the European Atherosclerosis Society鈥檚 Consensus statement on Lipoprotein(a).
Dr. Virani firmly believes in the notion of Civil Society that one of the most important objectives of being able to acquire quality education is to serve the communities in which we live and the communities in need. In that respect, he spends ~15-20 hours per week in voluntary service with a dedicated team of volunteers to (a) provide educational and behavioral intervention related resources to combat NCDs in the community (b) play an active role in health care capacity building for communities in South Asia, Central Asia, and East Africa. He also serves on the World Heart Organization鈥檚 Technical Advisory Group on NCD related research and innovation (TAG/RI).
Selected Publications
-
Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, Rivadeneira F, Uitterlinden AG, Hofman A, Witteman JC, Pencina MJ, Folsom AR, Cupples LA, Ballantyne CM, Boerwinkle E. " " Atherosclerosis. 2012 Aug ; 223 (2) : 421-6.
Pubmed PMID: . -
Negi SI, Brautbar A, Virani SS, Anand A, Polisecki E, Asztalos BF, Ballantyne CM, Schaefer EJ, Jones PH. " " J Clin Lipidol. 2013 Jan ; 7 (1) : 82-7.
Pubmed PMID: . -
Virani SS, Pompeii L, Lincoln AE, Dunn RE, Tucker AM, Nambi V, Nasir K, Vogel RA, Boone JL, Roberts AJ, Ballantyne CM. " " Atherosclerosis. 2012 Jun ; 222 (2) : 551-6.
Pubmed PMID: . -
Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W, Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. " " 2012 Jan 10;
Pubmed PMID: .
Languages
Gujarati, Hindi, Urdu
to edit your profile